Bio-Techne (TECH) Total Non-Current Liabilities (2014 - 2026)

Bio-Techne's (TECH) quarterly Total Non-Current Liabilities came in at $2.5 billion in Q1 2026, down 3.79% year-on-year from $2.6 billion in Q1 2025, and up 1.17% quarter-over-quarter from $2.5 billion in Q4 2025.

Bio-Techne (TECH) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Bio-Techne's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 3.79% year-over-year to $2.5 billion in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 3.79% decrease from a year earlier, with the FY2025 full-year figure at $2.5 billion, down 5.94% from the prior year.
  • Total Non-Current Liabilities rose to $2.5 billion in Q1 2026 per TECH's latest filing, from $2.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.7 billion in Q3 2023 and bottomed at $2.3 billion in Q1 2022.
  • The 5-year median for Total Non-Current Liabilities is $2.6 billion (2023), against an average of $2.6 billion.
  • Across the five-year window, Total Non-Current Liabilities advanced 17.39% in 2023 and decreased 7.87% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $2.4 billion in 2022, then climbed by 15.36% to $2.7 billion in 2023, then declined by 2.0% to $2.7 billion in 2024, then slipped by 6.0% to $2.5 billion in 2025, then advanced by 1.17% to $2.5 billion in 2026.
  • Per Business Quant, the three latest TECH Total Non-Current Liabilities figures stand at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 2.53 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.53 Bn
Dec 31, 2025 2.50 Bn
Sep 30, 2025 2.50 Bn
Jun 30, 2025 2.53 Bn
Mar 31, 2025 2.63 Bn
Dec 31, 2024 2.66 Bn
Sep 30, 2024 2.72 Bn
Jun 30, 2024 2.69 Bn
Mar 31, 2024 2.71 Bn
Dec 31, 2023 2.71 Bn
Sep 30, 2023 2.75 Bn
Jun 30, 2023 2.63 Bn
Mar 31, 2023 2.59 Bn
Dec 31, 2022 2.35 Bn
Sep 30, 2022 2.34 Bn
Jun 30, 2022 2.29 Bn
Mar 31, 2022 2.29 Bn
Dec 31, 2021 2.30 Bn
Sep 30, 2021 2.25 Bn
Jun 30, 2021 2.24 Bn